CytRx   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Los Angelos CA United States (1985)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
1997
NCT00004408
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chief Medical Officer, CytRx Corporation | CytRx Coorporation | CytRx Coporation